Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Dutasteride effectively and safely treats male hair loss for over a year.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Large prostates link to more hair loss.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

Baldness score can't be used to predict prostate size.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Finasteride may decrease semen quality but not harm sperm production, and stopping the drug can improve semen quality; hyperprolactinemia can cause infertility but is treatable with medication.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

The care model improved timely diagnosis and treatment for psoriasis and psoriatic arthritis.

Obesity is linked to more severe lower urinary tract symptoms.

More research with diverse participants is needed to determine the effectiveness of photobiomodulation devices for hair loss treatment.

Patients need better information about the risks of long-term steroid use.

A woman with type 2 diabetes developed alopecia areata, suggesting a link between the two autoimmune conditions.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

The IPP index is linked to storage symptoms and leftover urine, and may help manage urinary tract symptoms.

Biofeedback treatment for dysfunctional voiding in adults showed no symptom improvement.

Some patients fail bladder function tests due to lower flow rates and higher remaining urine volumes, but the exact reasons for failure are unclear.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Saw palmetto can help with prostate issues and may promote hair growth.

Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.

Being obese and eating too many calories may increase the risk of kidney cancer, but physical activity doesn't seem to affect this risk.

Patients follow treatment well, but many change medicines; good information helps compliance.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.